Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by xodcode on Jun 13, 2024 3:05pm

June 21 PP

I would hope that TLT management have a large prospective partner lined up who will sop up any unclaimed shares on June 21. After all, $10 million isn't a large commitment for any large pharma or other whale who believes in the content of the latest news releases . Interesting times ahead to be sure A successful $10 million PP lays the groundwork for future significant TLT price increments.
Comment by CancerSlayer on Jun 13, 2024 3:32pm
I think a smaller to mid-sized company/player would fit this level of funding.  I don't think Big Pharma would have any interest in a partial equity deal of this small magnitude, or of any magnitude for that matter.  Whales generally like to swallow their meals whole, not in pieces.  JMO.
Comment by Oilminerdeluxe on Jun 13, 2024 3:37pm
Unless they have a player lined up, there is no reason to expect another outcome compared to the recent raises. With a little luck, it will be enough to get us to BTD, But that appears to easily get kicked further down the road timewise. If not, Q4 could be a doozy. Let's hope for that. 
Comment by DJDawg on Jun 13, 2024 3:47pm
The problem of getting to BTD is that BTD alone won't be enough as people will expect BTD to be followed by PP announcement. Need to get BTD and some other financial information that shows that another PP won't happen instantly. It's a broken trust now. None of us trust them NOT to do a PP every 2 months.
Comment by xodcode on Jun 13, 2024 3:46pm
Given the difficulty with the recent $1 million PP's, it is difficult to imagine how TLT management plan to raise $10 million at $0.22 unless they already have a commitment, one with strings attached like milestone promises going forward, Kind of a quasi JV commitment! I remain very optimistic especially with the expanded available markets implied by the recent news releases.
Comment by CancerSlayer on Jun 13, 2024 4:20pm
I agree that this significant $ amount suggests there is already a commitment in play.  You may be right, & perhaps this is the smarter play by Pharma to get its foot in the door of a more de-risked partnership/JV (compared to a 100% buyout) with exclusivity rights & incentives/milestone payments attached, which may include the attainment of a BTD.  JMO. You can strike my prior ...more  
Comment by Lesalpes29 on Jun 13, 2024 4:36pm
And it's a cheap way to get a relatively good chunk of shares at a good price with warrants. We will see.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250